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Objective: Chondrocytes respond to insulin, but the presence and role of the speciﬁc high afﬁnity insulin
receptor (InsR) has never been demonstrated. This study determined whether human chondrocytes
express the InsR and compared its abundance and function in normal and osteoarthritis (OA) human
chondrocytes.
Design: Cartilage sections were immunostained for detection of the InsR. Non-proliferating chondrocyte
cultures from normal and OA human cartilage were treated with 1 nM or 10 nM insulin for various
periods. InsR, insulin-like growth factor receptor (IGFR), aggrecan and collagen II mRNA levels were
assessed by real time RT-PCR. InsR, glucose transporter (GLUT)-1, phospho-InsRbeta and phospho-Akt
were evaluated by western blot and immunoﬂuorescence. Glucose transport was measured as the uptake
of [3H]-2-Deoxy-D-Glucose (2-DG).
Results: Chondrocytes staining positively for the InsR were scattered throughout the articular cartilage.
The mRNA and protein levels of the InsR in OA chondrocytes were approximately 33% and 45%,
respectively, of those found in normal chondrocytes. Insulin induced the phosphorylation of the InsRbeta
subunit. Akt phosphorylation and 2-DG uptake increased more intensely in normal than OA chon-
drocytes. Collagen II mRNA expression increased similarly in normal and OA chondrocytes while
aggrecan expression remained unchanged. The Phosphoinositol-3 Kinase (PI3K)/Akt pathway was
required for both basal and insulin-induced collagen II expression.
Conclusions: Human chondrocytes express functional InsR that respond to physiologic insulin concen-
trations. The InsR seems to be more abundant in normal than in OA chondrocytes, but these still respond
to physiologic insulin concentrations, although some responses are impaired while others appear fully
activated. Understanding the mechanisms that regulate the expression and function of the InsR in
normal and OA chondrocytes can disclose new targets for the development of innovative therapies for
OA.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Insulin was shown to induce anabolic and inhibit catabolic
responses in adult chondrocytes. In particular, insulinwas shown to
promote collagen II and proteoglycan synthesis1,2 and to inhibit
Interleukin-1(IL-1)b-induced catabolic effects in adultto: A.F. Mendes, Center for
3004-517 Coimbra, Portugal.
s Research Society International. Pchondrocytes and cartilage explant cultures from various species3.
Insulin also plays an important role in chondrogenesis as an
inducer of chondrocyte differentiation4 and was recently shown to
reverse the cartilage loss associated with impaired fracture healing
in diabetic mice5. Moreover, insulin was shown to ameliorate
cartilage degeneration in a mouse model of osteoarthritis (OA)
while its anabolic and anti-catabolic effects seemed to be inde-
pendent of aging or disease state3.
Despite this, little attention has been devoted to the role of
insulin in modulating adult articular chondrocyte functions other
than the synthesis and degradation of proteoglycans and collagen II.ublished by Elsevier Ltd. All rights reserved.
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important since it is a major function of insulin in target tissues.
Besides its major effect on the facilitative glucose transporter
(GLUT)-4, a member of the facilitative glucose/polyol or GLUT/
solute carrier (SLC)2A transporter family, expressed in skeletal
muscle and adipose tissue cells, insulin was shown to increase
glucose transport in other cell types, by promoting the expression
and plasma membrane incorporation of GLUT-16-9. Glucose is an
essential nutrient for chondrocytes, being required for energy
production, basically through the glycolytic pathway, and for the
proper synthesis of cartilage matrix macromolecules, namely
proteoglycans. Facilitated glucose transport represents the ﬁrst
rate-limiting step in glucose metabolism in chondrocytes and thus
its regulation is a critical determinant of chondrocyte homeo-
stasis10. Several members of the GLUT family were identiﬁed, at the
protein level, in human chondrocytes, including GLUTs-1, -3, -6, -8,
-9 and -10, but not GLUT-410,11. Among these, GLUT-1 seems to be
especially important since it is regulated by anabolic, namely IGF-I,
and catabolic stimuli10e13, as well as by the extracellular glucose
concentration14.
It is unclear, however, whether physiologic nanomolar concen-
trations of insulin, which can reach chondrocytes by simple diffu-
sion from the synovial ﬂuid15, are able to promote anabolic gene
expression and tomodulate glucose transport in chondrocytes. This
is especially important since many of the studies conducted so far
used high supraphysiologic insulin concentrations1,2. In the few
studies where insulin was used in the nanomolar range, the pres-
ence and role of the speciﬁc high afﬁnity insulin receptor (InsR) in
mediating insulin-induced responses were not demonstrated3.
Since insulin also binds to the structural- and functionally-related
insulin-like growth factor receptor (IGFR), although with lower
afﬁnity thus requiring higher concentrations16, the question
remains as to the presence and role of the InsR in mediating
insulin-induced responses in chondrocytes.
Therefore, the ﬁrst objective of this study was to determine
whether adult human chondrocytes express the InsR and to compare
its abundance in normal andOAchondrocytes. Then,we investigated
whether the insulin receptors expressed in normal and OA chon-
drocyteswere functional byexamining the abilityof insulin to induce
its phosphorylation and the activation of the Phosphoinositol-3
Kinase (PI3K)/Akt (or protein kinase B) pathway, which is a major
downstream effector of the InsR. To elucidate the role of the InsR in
mediating the anabolic effects of insulin, we analyzed the mRNA
expression of aggrecan and collagen II. Finally, we investigated the
role of insulin and the InsR in modulating glucose transport and
GLUT-1 content in normal and OA chondrocytes.
Materials and methods
Cartilage samples and chondrocyte cultures
Human knee cartilage was collected from the distal femoral
condyles of 24 multi-organ donors (11 women and 13 men, 18e53
years old, mean¼ 38,) or with informed consent from 29 patients
(14 women, 15 men, 58e82 years old, mean¼ 67) undergoing total
knee replacement surgery at the Orthopedic Department of the
University Hospital of Coimbra (HUC). The Ethics Committee of
HUC approved all procedures. Normal cartilage had nomacroscopic
signs of degradation or osteophytosis. Cartilage from patients was
severely damaged, with areas of extensive full thickness erosion.
Chondrocytes were isolated by enzymatic digestion from non-
pooled cartilage samples as described previously17. To avoid
dedifferentiation, conﬂuent non-proliferating monolayer cultures
were established from each cartilage sample, allowed to recover in
medium containing 5% fetal bovine serum for 24 h, serum-starvedovernight and maintained thereafter in serum-free culture
medium. Serum-starved chondrocyte cultures were treated with
1 or 10 ng/ml recombinant human insulin (Sigma Chemical Co.,
St. Louis, MO), as indicated in the Results section and ﬁgure legends.
Total RNA extraction, CDNA preparation and quantitative real-time
RT-PCR (qRT-PCR)
Total RNA was extracted with TRIzol (Invitrogen, Paisley, UK),
analyzed using Experion RNA StdSens Chip (Bio-Rad) and quantiﬁed
in a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technolo-
gies, Inc., Wilmington, DE) at 260 nm. The cDNA was reverse tran-
scribed from 1 mg of total RNA, using iScriptTM Select cDNA
Synthesis Kit (Bio-Rad), according to themanufacturer’s instructions.
The cDNA obtained was stored at 20C until further analysis.
Speciﬁc sets of primers were designed using Beacon Designer soft-
ware (PREMIER Biosoft International, Palo Alto, CA). Details of the
forward and reverse primers used are presented in Table I. The
stability values for the expression of reference gene candidates were
obtained by a Normﬁnder analysis using Genex software (MultiD
Analyses AB). The results obtained (Supplemental table) indicated
that HPRT-1 is the best reference gene for comparisons between
normal and OA chondrocytes, while RPL13A is the best to evaluate
insulin-induced responses. qRT-PCRwas performedwith iTaq DNA
polymerase using iQ SYBR Green Supermix (Bio-Rad). Thermal
cycling conditions included 3 min at 95C to activate the iTaq DNA
polymerase, followed by 45 cycles, each consisting of a denaturation
step at 95C for 10 s, an annealing step at 54C for 30 s and an
elongation step at 72C for 30 s. Fluorescence measurements were
taken every cycle at the end of the annealing step and the speciﬁcity
of the ampliﬁcation products was checked by analysis of the melting
curve. The efﬁciency of the ampliﬁcation reaction for each gene was
calculated by running a standard curve of serially diluted cDNA
sample. In each assay, a control reaction without the cDNA was also
subjected to PCR ampliﬁcation.
Gene expression levels in normal and OA chondrocytes were
normalized to HPRT-1 using the following formula EDCt, where E is
the qPCR efﬁciency of the genes evaluated and DCt is the difference
between the cycle threshold (Ct) of HPRT-1 and that of each gene of
interest. Gene expression changes relative to a control condition
were analyzed using the built-in iQ5 Optical system software v2,
which enables the analysis of the results with the Pfafﬂ method18,
a variation of the DDCT method corrected for gene-speciﬁc
efﬁciencies.
Western blot analysis
Total cell extracts were prepared as previously described14. The
extracts and molecular weight markers (All blue, Precision Plus
molecular weight markers, Bio-Rad Laboratories Inc., Hercules, CA)
were subjected to SDS/PAGE, electroblotted onto PVDFmembranes,
probed with rabbit polyclonal antibodies against the b subunit of
the InsR (InsRbeta) (1:1000 dilution; Santa Cruz Biotechnology, Inc,
Santa Cruz, CA), the Ser 473-phosphorylated form of Akt (pAkt)
(1:1000 dilution; Cell Signaling Technology, Danvers, MA) or the
human GLUT-1 (1:4000 dilution; FabGennix Inc. International,
Frisco, TX) and then with an alkaline phosphatase-conjugated
secondary antibody (1:20,000 dilution; GE Healthcare). A mouse
monoclonal antibody against the phosphorylated form of the
InsRbeta subunit (1:200 dilution, Santa Cruz Biotechnology) was
used to detect the activated form of the InsR (pInsRbeta). Immune
complexes were detected with the Enhanced ChemiFluorescence
reagent (GE Healthcare) in a Storm 840 scanner (GE Healthcare). A
mouse anti-actin monoclonal antibody (1:10,000 dilution; Milli-
pore Corporation, Billerica, MA) was used as a loading control. The
Table I
Oligonucleotide primer pairs used for qRT-PCR
Gene Primer sequences (50e30) RefSeq ID
b-Actin (ACTB) F: AACTACCTTCAACTCCAT
R: TGATCTTGATCTTCATTGTG
NM_001101
Beta-2-microglobulin (B2M) F: CTCCAAAGATTCAGGTTTACTCAC
R: AGTCAACTTCAATGTCGGATGG
NM_004048
Peptidylprolyl isomerase A (Cyclophilin A) F: CAGTCCCAGGAAGTGTCAATG
R: CAGCGTCTCACTATGTTGCC
NM_021130
Hypoxanthine phosphoribosyltransferase-1 (HPRT-1) F: TGACACTGGCAAAACAAT
R: GGCTTATATCCAACACTTCG
NM_000194
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) F: ACAGTCAGCCGCATCTTC
R: GCCCAATACGACCAAATCC
NM_002046
Ribosomal protein S18 (18S rRNA) F: GAAGATATGCTCATGTGGTGTTG
R: CTTGTACTGGCGTGGATTCTG
NM_022551
Ribosomal protein L13a (RPL13A) F:GGAAGAGCAACCAGTTACTATGAG
R:CAGAGTATATGACCAGGTGGAAAG
NM_012423
TATA box binding protein (TBP) F: TTCCACTCACAGACTCTC
R: ACAATCCCAGAACTCTCC
NM_003194
InsR F: GCCTCTACAACCTGATGAAC
R: ACAGATGTCTCCACACTCC
NM_000208
IGFR F: GAAGTGAGTGCTCCTTGATG
R: CCACGGATGACTGCTGAG
NM_000875
Collagen type II (COL2A1) F: GGC AGA GGT ATA ATG ATA AGG
R: ATT ATG TCG TCG CAG AGG
NM_001844
Aggrecan (ACAN) F: CCT GGT GTG GCT GCT GTC
R: CTG GCT CGG TGG TGA ACT C
NM_001135
F: Forward sequence; R: Reverse sequence
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(GE Healthcare).
Immunoﬂuorescence staining
Five mm diameter full thickness cartilage cylinders were
collected from the distal femoral condyles of multi-organ donors,
immersed in OCT embedding compound (TAAB Laboratories, UK)
and immediately frozen at 80C. Cryostat sections, 10 mm thick,
were ﬁxed in methanol at 20C for 10 min. Chondrocytes
cultured on glass coverslips were ﬁxed in 4% paraformaldehyde at
4C for 10 min and permeabilized with 0.1% Tween-20 in PBS for
10 min. For immunostaining of ﬁxed cartilage sections and chon-
drocytes, a rabbit polyclonal antibody to the InsRbeta subunit
(1:50 dilution; Santa Cruz Biotechnology) and Alexa ﬂuor 488-
conjugated goat anti-rabbit antibody (1:200 dilution; Molecular
Probes, Eugene, OR) were used as primary and secondary anti-
bodies, respectively. Counterstaining was performed with DAPI
(Sigma) to allow nucleus visualization. Speciﬁcity was assessed by
omitting the ﬁrst antibody (negative control). Images of cartilage
sections were acquired in a PALM laser dissector ﬂuorescence
microscope (Zeiss Axiovert 200M) and images of cultured chon-
drocytes were acquired in a confocal laser scanning microscope
(Zeiss LSM 510 Meta), using an excitation ﬁlter of 500 nm and an
emission ﬁlter of 520 nm. The settings for contrast, brightness,
acquisition mode and scanning time were maintained throughout
the work in both microscopes.
2-Deoxy-D-Glucose (2-DG) uptake assay
Glucose transport was measured as the net uptake of 2-DG
(Sigma), a non-metabolizable analog of glucose, as previously
described14.Statistical Analysis
The two-tailed unpaired Student t-test was used to compare the
mRNA and protein levels of the InsR and the IGFR mRNA levels in
normal and OA chondrocytes. In all other ﬁgures and tables, the
statistical analysis was performed using the one-tailed or two-
tailed Student t-test for paired data. To assess normality for the
observations themselves or for the observed differences, a graph-
ical analysis based on normal quantile plots was used and showed
no strong departure from normality thus supporting the use of the
Student t-test. Each subject contributed only one cartilage sample.
Single measurements of the various parameters being analyzed
were obtained from each cartilage sample, except in qRT-PCR and
2-DG uptake where triplicates and duplicates, respectively, were
analyzed. Nonetheless, multiple measurements contributed only
once (as mean value) to the statistical analysis. Results are pre-
sented as mean values with 95% conﬁdence intervals (95% CI), and
were considered statistically signiﬁcant for P< 0.05.
Results
In situ immunoﬂuorescence staining of the InsR in normal human
cartilage
Figure 1(A) shows chondrocytes staining positively for the
InsRbeta subunit scattered throughout adult human cartilage, as
indicated by the green ﬂuorescence around nuclei stained in blue.
Nonetheless, several chondrocytes are also present that show no
staining. The absence of green staining in Fig. 1(B) (negative
control) demonstrates the speciﬁcity of the staining in panel A.
Therefore, these results demonstrate that the InsR is present at the
protein level in adult human chondrocytes in situ in the articular
cartilage.
Fig. 1. In situ Immunoﬂuorescence staining of the InsR in normal human cartilage.
(A) representative image of the InsRbeta subunit (green) in normal human cartilage
sections (N¼ 3) counterstained with DAPI (blue) to allow nuclei visualization, viewed
with a 200 magniﬁcation (inset: 400 magniﬁcation). (B) representative image of
the negative control (N¼ 3) viewed with a 200 magniﬁcation (inset:
400 magniﬁcation).
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OA human articular cartilage
The results show that adult human chondrocytes, either normal
or OA, express both the insulin and the IGF-I receptors at the mRNA
level. However, the InsRmRNA level is 33% lower (P¼ 0.0028) in OA
(mean¼ 6.1, 95% CI¼ 2.9e6.4, N¼ 7) than in normal (mean¼ 9.1,
95% CI¼ 7.7e10.6, N¼ 8) chondrocytes. Similarly, the abundance of
the IGFR mRNA is 52.5% lower (P¼ 0.0149) in OA (mean¼ 2.2, 95%
CI¼ 1.9e2.6, N¼ 7) than in normal (mean¼ 4.6, 95% CI¼ 2.8e5.4,
N¼ 8) chondrocytes.
InsR protein levels in chondrocytes from normal and OA human
articular cartilage
The InsR expressed in chondrocytes was further characterized at
the protein level bywestern blot and immunoﬂuorescence staining.
The antibody used in the western blot analysis is speciﬁc for the
b subunit of the InsR, detecting both its precursor (PreInsR) and
mature (InsRbeta) formswhich have apparentmolecular weights of
200 and 90 kDa, respectively. Accordingly, the two bands weredetected both in a whole cell extract of 3T3-L1 adipocytes used as
a positive control (PC) and in the whole cell extracts obtained from
normal and OA chondrocytes [Fig. 2(A)]. The levels of either form of
the InsR were found to be signiﬁcantly higher in normal than in OA
chondrocytes, in which they represent 53.1% and 55.9%, respec-
tively, of those found in normal chondrocytes [Fig. 2(A)]. Immu-
noﬂuorescence staining of normal and OA chondrocyte cultures
[Fig. 2(B)] conﬁrmed the results of the western blot analysis,
showing a punctuated staining pattern consistent with the plasma
membrane localization of the InsR that is more intense in normal
than in OA chondrocytes.
Evaluation of the functional state of the InsR expressed in normal
and OA human chondrocytes
To determine whether the InsR expressed in normal and OA
human chondrocytes is functional and mediates insulin-induced
responses, we evaluated the ability of nanomolar insulin concen-
trations to induce the phosphorylation of Tyrosine residues in
positions 1150 and 1151 of the beta subunit of the InsR and the
phosphorylation of the Serine 473 residue of Akt.
Treatment of normal and OA chondrocytes with 10 nM insulin
induced the phosphorylation of the InsRbeta subunit, in a time-
dependent manner [Fig. 3(A)]. Normal and OA chondrocytes have
a similar basal Akt phosphorylation, which was markedly increased
by treatment with 1 nM and 10 nM insulin both in normal
[Fig. 3(B)] and OA chondrocytes [Fig. 3(C)]. However, in OA chon-
drocytes, Akt phosphorylation induced by either insulin concen-
tration was lower than that observed in normal ones.
Role of insulin and its speciﬁc receptor in modulating aggrecan and
type II collagen gene expression
To further characterize the functions of the InsR, insulin-
induced anabolic gene expression, namely aggrecan and type II
collagen, were evaluated by qRT-PCR. Treatment of normal human
chondrocytes with 10 nM insulin for 12 h (mean¼ 1.002, 95%
CI¼ 0.72e1.28, P¼ 0.5089, N¼ 5) did not alter aggrecan mRNA
levels relative to untreated cells, whereas it induced a 2.4 fold
increase in type II collagen mRNA level (Table II).
To further elucidate the mechanisms by which the InsR medi-
ates insulin-induced collagen II expression, speciﬁc inhibitors of
PI3K (wortmannin) and MEK1/MEK2 (U0126) were added to the
chondrocyte cultures 30 min before addition of 10 nM insulin for
12 h. Treatment with wortmannin alone for the same period
signiﬁcantly decreased basal collagen II mRNA levels, while in
insulin-treated chondrocytes, it returned collagen II mRNA levels to
those found in untreated cells (Table II). The MEK1/MEK2 inhibitor
slightly increased collagen II mRNA levels relative to untreated
cells, but had no effect on insulin-induced collagen II expression.
To determine whether the InsR is still functional in OA chon-
drocytes, we measured collagen II mRNA levels in response to
insulin. Basal mRNA levels did not differ signiﬁcantly between
normal and OA chondrocytes (data not shown). Treatment of OA
chondrocytes with 10 nM insulin for 12 h increased collagen II
mRNA levels to 2.0 (95% CI¼ 0.8e3.3, P¼ 0.0455, N¼ 4) of those
found in untreated cells, which, although barely reaching statistical
signiﬁcance, is a response of magnitude similar to that observed in
normal chondrocytes.
Regulation of glucose transport and GLUT-1 content by insulin in
normal and OA chondrocytes
To determine the role of insulin and its speciﬁc receptor in the
regulation of glucose transport, we measured 2-DG uptake in
Fig. 2. InsR protein levels in chondrocytes from normal and OA human articular cartilage. (A) preInsR and InsRbeta protein content in total cell extracts of chondrocyte cultures
established from normal (N¼ 6) and OA (N¼ 6) non-pooled cartilage samples. The image shown is representative of the results obtained in normal and OA chondrocytes.
MW¼molecular weight marker; N¼ normal chondrocytes; OA¼ osteoarthritic chondrocytes. (B) Immunoﬂuorescence staining of the InsRbeta subunit (green) expressed in
normal and OA chondrocytes counterstained with DAPI (blue) to show the cell nuclei, as described under “Immunoﬂuorescence staining” in the Materials and methods section. The
images shown are representative of the results obtained in 3 normal and 3 OA independent chondrocyte cultures; NC¼Negative control.
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with 1 nM and 10 nM insulin for 48 h increased 2-DG uptake in
a concentration-dependent manner relative to untreated cells
(Table III). In OA chondrocytes, however, the increase in 2-DG
uptake induced by insulin was lower than in normal ones and the
difference between the responses induced by the two insulin
concentrations tested did not reach statistical signiﬁcance.To elucidate the mechanism by which insulin increased 2-DG
uptake, total GLUT-1 protein content was analyzed by western
blot in total cell extracts from normal and OA chondrocytes.
Treatment with 10 nM insulin increased total GLUT-1 protein
content in normal [Fig. 4(A)], but not in OA chondrocytes
[Fig. 4(B)], whereas 1 nM insulin had no effect, either in normal or
OA chondrocytes.
Fig. 3. Evaluation of the functional state of the InsR expressed in normal and OA human chondrocytes. (A) InsRbeta phosphorylation in chondrocyte extracts from 1 normal
and 2 OA cartilage samples untreated (Control) or treated with insulin 10 nM for the indicated periods. Akt phosphorylation in total cell extracts from 4 normal (B) and 4 OA (C) non-
pooled independent chondrocyte cultures treated with 1 or 10 nM insulin for 30 min relative to untreated cells.
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The results obtained in this study demonstrate for the ﬁrst time
that adult human chondrocytes express the InsR, both in situ in the
articular cartilage (Fig. 1) and in vitro after isolation and culture
(Fig. 2). In agreement with this, a physiologic nanomolar insulin
concentration was effective in directly activating the InsR both in
normal and OA chondrocytes, thus indicating that the InsR
expressed in human chondrocytes is functional. Consistent with
this, insulin also induced Akt phosphorylation in normal and, to
a lesser extent, in OA chondrocytes (Fig. 3). This ﬁnding, together
with the low insulin concentrations tested that are unlike to be
sufﬁcient to activate the IGFR16, further support the involvement of
the speciﬁc InsR in mediating Akt activation induced by physiologic
insulin concentrations. On the other hand, the lower response of OA
chondrocytes to the same insulin concentrations can directly resultTable II
Role of signaling pathway inhibitors on collagen type II gene expression relative to
untreated cells
Insulin,
10 nM, 12 h
Inhibitor Mean (95% CI) P value N
þ e 2.48 (1.24e3.72) 0.0138* 6
e Wortmannin, 200 nM 0.41 (0.31e0.50) 0.0014* 3
þ Wortmannin, 200 nM 0.80 (0.73e0.88) 0.9962*/0.0021y 3
e U0126, 10 mM 1.21 (1.17e1.25) 0.0022* 3
þ U0126, 10 mM 2.14 (1.18e3.10) 0.0180*/0.8556y 3
* vs untreated cells
y vs insulin, 10 nMfrom reduced expression of the InsR (Fig. 2), as well as from
defective downstream signaling.
Several processes can contribute to the reduced expression of the
InsR in OA chondrocytes. The InsR is regulated both at the tran-
scriptional and post-transcriptional levels by glucocorticoids19,
insulin19,20 and nutrient availability20e22. Additionally, inﬂamma-
tory mediators, like IL-1, TNF-a and reactive oxygen species (ROS)
which play an important role in OA23,24, may also contribute to
downregulate the InsR and/or its downstream signaling pathways.
Indeed, studies in endothelial cells demonstrated that TNF-a
decreases the InsR content25. Moreover, TNF-a, IL-1 and ROS have all
been shown to inhibit the generation of downstream signaling
intermediates26e29, leading to insulin resistance. Accordingly, the
lower InsR content and the reduced Akt activation in OA chon-
drocytes relative to normal onesmay be another consequence of the
accumulation and actions of those inﬂammatory and catabolic
mediators in osteoarthritic joints. On the other hand, given the
different mean age of the normal and OA groups analyzed, the
inﬂuence of aging on the decreased InsR expression and function in
OA chondrocytes cannot be excluded. Nonetheless, since aging is the
major risk factor for OA, elucidation of themechanisms that regulate
the InsR expression and function in human chondrocytes and how
these are affected by aging and OA deserve further investigation.
We also found the IGFR expression to be decreased in OA rela-
tive to normal chondrocytes. This is likely to contribute to the
reported resistance of OA chondrocytes to IGF-I, along with other
mechanisms already identiﬁed30,31. Similarly, the lower InsR
expression and activity in OA chondrocytes suggest that these may
also have some degree of insulin resistance. However, although less
Table III
Regulation of 2-DG uptake by insulin in normal and OA chondrocytes
Relative 2-DG uptake (% of untreated cells)
Insulin, nM Normal OA
Mean (95% CI) P N Mean (95% CI) P N
1 125 (118-132) 1.16e-05* 16 112 (107e117) 0.0049* 8
10 141 (134-147) 5.78e-10*/0.0084y 18/12 123 (118e129) 3.8e-07*/0.0511y 16/4
* vs untreated cells
y vs insulin, 1 nM
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physiologic insulin concentrations [Fig. 3(B)], indicating that they
are partially sensitive to insulin which can contribute to sustain
chondrocyte functions, since Akt is upstream of key survival and
metabolic pathways31.
To elucidate this question, we determined whether insulin
signaling through its speciﬁc receptor can promote anabolic
responses, namely aggrecan and collagen II expression, both in
normal and OA chondrocytes. Under the experimental conditions
used, the mRNA expression of aggrecan was not affected, while
collagen II mRNA levels were increased by treatment of humanFig. 4. Regulation of GLUT-1 content by insulin in normal and OA chondrocytes.
Total GLUT-1 protein levels in (A) normal (N¼ 6) and (B) OA (N¼ 6) chondrocytes
treated with 1 or 10 nM insulin for 48 h relative to untreated cells.chondrocytes with a physiologic insulin concentration (Table II). In
addition, collagen II expression involved a mechanism partly
dependent on the PI3K, but not on the MEK1/MEK2 pathway
(Table II). This demonstrates that, at least, some anabolic responses
in human chondrocytes are physiologically regulated by activation
of the InsR. Although expressing lower levels of the InsR, the ability
of OA chondrocytes to express collagen II in response to insulinwas
found to be similar to that observed in normal chondrocytes. This
suggests that the remaining InsR molecules are sufﬁcient to ensure
full or nearly full induction of collagen II expression. Nonetheless,
this ﬁnding is somewhat puzzling since OA chondrocytes showed
defective Akt activation [Fig. 3(B)] and the InsR-mediated collagen
II expression was found to involve the PI3K (Table II), which taken
together would predict a lower ability of OA chondrocytes to
express collagen II mRNA in response to insulin. In agreement with
this, the difference in collagen II mRNA levels between insulin-
treated and untreated OA chondrocytes barely reached statistical
signiﬁcance, likely reﬂecting a signiﬁcant variability between
individuals. This suggests that some individuals with OA will
respond less effectively to physiologic insulin concentrations in
terms of collagen II expression, which in the current study may
have been underestimated due to the small sample size available.
Further studies with larger cohorts of OA patients stratiﬁed by age,
sex, comorbidities and possibly other individual variables may help
elucidate which patients will more likely respond to physiologic
insulin concentrations. Moreover, identiﬁcation of the signaling
pathways involved in InsR-mediated collagen II expression and
evaluation of their activity in normal and OA chondrocytes deserves
further investigation as it may disclose novel mechanisms to
promote the chondrocyte anabolic responses.
The ﬁnding that, unlike collagen II, aggrecan expressionwas not
increased by low insulin concentrations is somewhat unexpected,
especially as other studies showed increased aggrecan and
proteoglycan production1,2. As these studies used high supra-
physiologic insulin concentrations, it is possible that the effects of
insulin on aggrecan and proteoglycan synthesis were mediated
solely by the IGFR. Nonetheless, it is also possible that insulin, even
in low physiologic concentrations, can increase the production of
proteoglycans acting by mechanisms independent of gene tran-
scription. Such studies are beyond the scope of the current study,
but areworthwhile being undertaken as new targets to increase the
chondrocyte anabolic activity may be disclosed.
To further characterize the role of physiologic insulin concen-
trations in regulating normal and OA chondrocyte functions, we
evaluated its ability to modulate glucose transport and observed
that it signiﬁcantly increased in normal and to a lesser extent in OA
chondrocytes (Table III). The highest insulin concentration tested
also augmented total GLUT-1 protein content in normal chon-
drocytes [Fig. 4(A)], suggesting that this contributed, at least in part,
to the observed increase in 2-DG uptake. In OA chondrocytes,
however, total GLUT-1 content remained unaffected with both
insulin concentrations [Fig. 4(B)]. In other cells, insulin was shown
to increase glucose uptake by promoting GLUT-1 incorporation in
the plasma membrane32. Other studies demonstrated that GLUT-1
S.C. Rosa et al. / Osteoarthritis and Cartilage 19 (2011) 719e727726exists in a dynamic equilibrium that involves the plasma
membrane, intracellular storage in the trans Golgi network and the
lysosomes where it is degraded14,33,34. Accordingly, the results
presented suggest that, even in concentrations as low as 1 nM
acting in OA chondrocytes, insulin can promote the recruitment of
GLUT-1 from intracellular stores to the plasma membrane. None-
theless, we also cannot exclude the possibility that other isoforms
of the GLUT family are involved in insulin-stimulated glucose
uptake in chondrocytes. Indeed, insulin has been shown to regulate
other GLUT isoforms, namely GLUTs-8 and -1235,36 which are
insulin sensitive and expressed by human chondrocytes, at least at
the mRNA level10,11. GLUT-3, which is constitutively expressed in
chondrocytes10 and in other cells was shown to be regulated by
insulin37, also deserves to be investigated as a possible insulin
target in human chondrocytes.
In conclusion, our results show for the ﬁrst time that adult
human chondrocytes express functional InsR. Even though
expressing lower InsR levels and showing defective activation of
Akt than normal ones, OA chondrocytes still seem capable of
responding to physiologic insulin concentrations. Even though the
relatively small number of cartilage samples available precludes
deﬁnitive conclusions to be taken, some responses, namely
glucose transport, seem to be impaired while others, like collagen
II mRNA expression, appear fully activated, at least in some
patients. The reduced ability of OA chondrocytes to increase
glucose transport in response to physiologic insulin concentra-
tions may compromise energy production and plastic functions,
namely glucosaminoglycan synthesis, what can contribute to
chondrocyte damage and OA progression. On the other hand,
taking into account the structural and functional homology
between the InsR and the IGFR, modulation of the InsR and of its
downstream signaling pathways may be an effective strategy to
overcome the resistance of OA chondrocytes to IGF-1, thus rep-
resenting a novel pharmacological target for the development of
innovative anti-osteoarthritic therapies.Author contributions
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